Senate Majority Leader Mitch McConnell, who has outsized power in deciding the Senate’s schedule, has not slated the Senate Finance Committee's drug pricing bill for a vote, largely because the package does not have widespread Republican support. In other pharmaceutical news: "one-and-done" therapies, generics lawsuits, and insulin costs.

from Kaiser Health News https://ift.tt/2MedcAq

Related Posts:

0 comments:

Post a Comment

Popular Posts